Short answer
Jade Biosciences, Inc. (JBIO) filed an 8-K current report with the SEC on April 2, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). 1,750,000 shares reserved under new 2026 Inducement Plan, creating potential dilution for existing shareholders.
Jade Biosciences, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- 1,750,000 shares reserved under new 2026 Inducement Plan, creating potential dilution for existing shareholders
- Equity awards limited to qualifying new hires under Nasdaq Rule 5635(c)(4), supporting recruitment without shareholder approval
- No incentive stock options permitted, restricting award types to nonqualified options, restricted stock units, or similar awards
- Plan terms substantially mirror the 2025 Stock Incentive Plan, with complete documents expected in the March 31, 2026 Form 10-Q
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Jade Biosciences, Inc. 8-K filings
Get the next JBIO 8-K as it lands
Follow JBIO for push alerts, or ask the research agent what this filing means.